FindTrial
Sign In

Combined use of multiple scales and MRI to determine the developmental outcome of high-risk infants

Combined use of multiple scales and MRI to determine the developmental outcome of high-risk infants

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021145
Enrollment
Unknown
Registered
2019-01-30
Start date
2019-01-30
Completion date
Unknown
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

high-risk infants

Interventions

Case series:None

Sponsors

The First Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. 0 months to 24 months of ages; 2. meet the diagnostic criteria for high-risk children; 3. patients and children with guardian informed consent to accept this clinical trial.

Exclusion criteria

Exclusion criteria: 1. There are effect indicators that may affect the study; 2. children with visual acuity and hearing abnormalities; 3. Those who voluntarily withdraw or lose their visits halfway.

Design outcomes

Primary

MeasureTime frame
GMs;GMs;The Neurological assessment of the preterm and full-term newborn infant;Carey Children's Temperament Series Assessment Questionnaire;Alberta Baby Sports Scale;Peabody Developmental Motor Scales;Gross motor function measure;Griffiths Development Assessment Scale;the hammersmith infant neurological examination;—

Countries

China

Contacts

Public ContactLING SHAN

the First Hospital of Jilin University

shanling19830605@163.com+86 15804303133

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026